Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

ClinicalTrials.gov ID: NCT02456740

Public ClinicalTrials.gov record NCT02456740. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.

Study identification

NCT ID
NCT02456740
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
955 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2015 (Actual)
Primary completion
Sep 5, 2016 (Actual)
Completion
Jun 19, 2017 (Actual)
Last update posted
Oct 12, 2022

2015 – 2017

United States locations

U.S. sites
59
U.S. states
26
U.S. cities
58
Facility City State ZIP Site status
Research Site Phoenix Arizona 85023 —
Research Site Anaheim California 92801 —
Research Site Encino California 91316 —
Research Site Irvine California 92618 —
Research Site Los Alamitos California 90720 —
Research Site Newport Beach California 92660 —
Research Site Rancho Mirage California 92270 —
Research Site Redlands California 92374 —
Research Site Sherman Oaks California 91403 —
Research Site Simi Valley California 93065 —
Research Site Spring Valley California 91978 —
Research Site Boulder Colorado 80301 —
Research Site East Hartford Connecticut 06118 —
Research Site Stamford Connecticut 06905 —
Research Site Waterbury Connecticut 06708 —
Research Site Bradenton Florida 34205 —
Research Site Jacksonville Florida 32256 —
Research Site Leesburg Florida 34748 —
Research Site Miami Florida 33135 —
Research Site Ocala Florida 34471 —
Research Site Orlando Florida 32801 —
Research Site Sunrise Florida 33351 —
Research Site West Palm Beach Florida 33407 —
Research Site Atlanta Georgia 30328 —
Research Site Boise Idaho 83704 —
Research Site Evansville Indiana 47714 —
Research Site Des Moines Iowa 50309 —
Research Site Newton Kansas 67114 —
Research Site Wichita Kansas 67207 —
Research Site Edgewood Kentucky 41017 —
Research Site Metairie Louisiana 70006 —
Research Site New Orleans Louisiana 70119 —
Research Site New Bedford Massachusetts 02740 —
Research Site Worcester Massachusetts 01605 —
Research Site Plymouth Minnesota 55441 —
Research Site Kansas City Missouri 64114 —
Research Site Springfield Missouri 65807 —
Research Site St Louis Missouri 63141 —
Research Site Amherst New York 14226 —
Research Site Plainview New York 11803 —
Research Site Rochester New York 14609 —
Research Site Durham North Carolina 27713 —
Research Site Greensboro North Carolina 27405 —
Research Site Cleveland Ohio 44122 —
Research Site Cleveland Ohio 44195 —
Research Site Willoughby Hills Ohio 44094 —
Research Site Portland Oregon 97210 —
Research Site Philadelphia Pennsylvania 19107 —
Research Site Cumberland Rhode Island 02864 —
Research Site Port Royal South Carolina 29935 —
Research Site Memphis Tennessee 38119 —
Research Site Nashville Tennessee 37203 —
Research Site Austin Texas 78731 —
Research Site Bedford Texas 76022 —
Research Site Irving Texas 75039 —
Research Site San Antonio Texas 78229 —
Research Site Salt Lake City Utah 84109 —
Research Site West Jordan Utah 84088 —
Research Site Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02456740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 12, 2022 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02456740 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →